Literature DB >> 16288744

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes.

Maiko Gokoh1, Seishi Kishimoto, Saori Oka, Yasuchika Metani, Takayuki Sugiura.   

Abstract

2-Arachidonoylglycerol (2-AG), an endogenous cannabionoid receptor (CB1 and CB2) ligand, enhanced the adhesion of HL-60 cells differentiated into macrophage-like cells to fibronectin and the vascular cell adhesion molecule-1. The CB2 receptor, Gi/Go, intracellular free Ca(2+) and phosphatidylinositol 3-kinase were shown to be involved in 2-AG-induced augmented cell adhesion. 2-AG also enhanced the adhesion of human monocytic leukemia U937 cells and peripheral blood monocytes. These results strongly suggest that 2-AG plays some essential role in inflammatory reactions and immune responses by inducing robust adhesion to extracellular matrix proteins and adhesion molecules in several types of inflammatory cells and immune-competent cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288744     DOI: 10.1016/j.febslet.2005.10.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

Authors:  G A Cabral; L Griffin-Thomas
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-09       Impact factor: 2.895

Review 2.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 3.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

4.  Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.

Authors:  L S Whyte; L Ford; S A Ridge; G A Cameron; M J Rogers; R A Ross
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

Authors:  François Chouinard; Caroline Turcotte; Xiaochun Guan; Marie-Chantal Larose; Samuel Poirier; Line Bouchard; Véronique Provost; Louis Flamand; Nathalie Grandvaux; Nicolas Flamand
Journal:  J Leukoc Biol       Date:  2012-12-12       Impact factor: 4.962

6.  The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells.

Authors:  Kevin Wilhelmsen; Samira Khakpour; Alphonso Tran; Kayla Sheehan; Mark Schumacher; Fengyun Xu; Judith Hellman
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

7.  The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.

Authors:  Torsten Lowin; Georg Pongratz; Rainer H Straub
Journal:  J Inflamm (Lond)       Date:  2016-05-05       Impact factor: 4.981

Review 8.  The CB2 receptor and its role as a regulator of inflammation.

Authors:  Caroline Turcotte; Marie-Renée Blanchet; Michel Laviolette; Nicolas Flamand
Journal:  Cell Mol Life Sci       Date:  2016-07-11       Impact factor: 9.261

Review 9.  Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach.

Authors:  Kamal Niaz; Fazlullah Khan; Faheem Maqbool; Saeideh Momtaz; Fatima Ismail Hassan; Navid Nobakht-Haghighi; Mahban Rahimifard; Mohammad Abdollahi
Journal:  EXCLI J       Date:  2017-05-15       Impact factor: 4.068

10.  Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury.

Authors:  Hamid Moradi; Fariba Oveisi; Elham Khanifar; Guillermo Moreno-Sanz; Nosratola D Vaziri; Daniele Piomelli
Journal:  Cannabis Cannabinoid Res       Date:  2016-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.